BADBIR

Delighted to represent the British Association of Dermatologists in receiving the ILDS 2025 Young Dermatologists International Achievement Award for Europe Hope our guidelines work can benefit people with skin diseases seeking care globally #Dermatology ilds.org/news-events/ne…

New publication @BADBIR, looking at the risk of suicide in patients with psoriasis and highlighting the need for prompt psychological assessment @ced_journal academic.oup.com/ced/advance-ar…

🎉 Today, on World Psoriasis Day, the GPA and @BADBIR team are fundraising for the Psoriasis Association! 🎉 We're raising awareness about the critical research and support for those living with psoriasis and psoriatic arthritis. #psoriasisawarenessweek2024 #PAW24 @PsoriasisUK

Listen now to the latest @_BDNG podcast with Professor Andrew Thompson and Dr Olivia Hughes. Focus on developing this valuable toolkit for families affected with EB. See details below how you can help.

Fantastic blog post from Dr. Zenas Yui @ZZNYiu on how to design a clinical research study! bad.org.uk/how-to-design-…

We look forward to seeing you at the 33rd Annual Conference @_BDNG 17 - 19 September 2024! Look out for @BADBIR in the foyer! Please join us for the @BADBIR update at 1pm on 17th September!

@epi_derm @sbidian @PsoriasisUK Our @BADBIR posters are up for another couple of hours - do come and take a look! #ISPEannual2024

Looking forward to hearing great talks and catching up with friends @IntPharmacoEpi #ISPEAnnual2024 #ICPE2024 over the next few days! Check out some of our @BADBIR work if you are there: Duc Binh Phan speaking on effectiveness of biosimilars - Monday 26/8 5:25pm Room III

Binh Phan is one of our #Psoriasis Association funded PhD students. You can now watch his talk "Evaluation of TNF Inhibitor Biosimilar Use in the UK: a study from @BADBIR" on our YouTube channel. Watch here ow.ly/AlRW50SztVV

What can we expect from @BADBIR (BAD Biologics Register) in the future? 🤔 Dr Zenas Yiu (@ZZNYiu) gives us an insight in his talk at our conference. Learn more about #BADBIR and how they collect data by watching the full talk on our YouTube. Watch here ow.ly/MNa850Szr2T

I’m delighted to present my work at the BAD. Using data of more than 15,000 patients we showed there is no increased risk of the development of keratinocyte carcinomas in psoriasis patients receiving biologic therapy compared to those on non-biologic systemic therapy.

We are looking forward to meeting so many of you at @HealthySkin4All BAD conference over the next couple of days. Here are a list of our BADBIR talks during the conference: #01072024" target="_blank" rel="nofollow noopener">badbir.org/News/#01072024 #BAD2024

I’m delighted to present my work on the “Risk of keratinocyte carcinomas in psoriasis patients treated with biologic therapy: analysis from BADBIR” as an oral presentation on Wednesday 3rd July at 11.15 Plenary session at the BAD annual meeting. So please join us!

I am honoured to share the stage with @ZZNYiu and @OrasAlabas and will cover the process of accessing data from one of the richest data sources on #psoriasis. So do come along and find out!

Looking forward to @HealthySkin4All #BAD2024 next week here in Manchester! I will be speaking at the Hot Topics in Hall 2.1 on Tuesday 2nd July on how to ask a research question in @BADBIR along with @OrasAlabas and Shehnaz Ahmed

We are at the @HealthySkin4All conference next week (July 2nd- July 4th)! You can find us at stand PSG 6. We have a few goodies on our stall for you! We look forward to meeting you all #BAD2024

February 2024's @BrJDermatol Plain Language Summaries are now available to view. The summaries aim to make #dermatology research findings more accessible to those without formal medical training. We've linked the summary which has a particular focus on #psoriasis below ⬇️

Here is our latest Eligibility criteria. We have recently opened recruitment to Spevigo (spesolimab) and small molecule Sotyktu (deucravacitinib)

Do you know anyone under the age of 18 or 50+ who would like to get involved in our photoshoot? We are looking for participants of all ages and ethnic backgrounds with any type of #psoriasis, but keen to see more representation from these particular age groups.📅 23rd & 24th Feb

@OrasAlabas @SalfordCO_NHS @FBMH_UoM @BADBIR @BrJDermatol Another helpful paper here, again led by colleagues @NCAlliance_NHS @FBMH_UoM @BADBIR: Risk of paradoxical eczema in patients receiving biologics for psoriasis jamanetwork.com/journals/jamad… Published by @JAMADerm